Xiaolin Zhu

First Affiliated Hospital of Heilongjiang University of Chinese Medicine — China

Medicine · Health Sciences

38h-index5.7kcitations372works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(124), Cancer, Lipids, and Metabolism(73), Cancer Immunotherapy and Biomarkers(28), Seed and Plant Biochemistry(22), Epigenetics and DNA Methylation(21)

Publications371 total

Activation and DNA methylation of PANoptosis in polycystic ovary syndrome
PLoS ONE·2026Open Access
Receptor identification and in vivo efficacy of a lytic phage vB_EcoStr-FJ63A against colistin-resistant Escherichia coli
Veterinary Research·2026Open Access
Pericyte-myofibroblast transition: a novel mechanism in peritoneal fibrosis and the effect of Asiaticoside
Journal of Advanced Research·2025Open Access
Supplementary Table 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Data 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 8. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 7. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Data 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 6. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 4. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Table 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 5. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Table 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Seasonal adjustments of basal metabolism and substrate metabolism in an Asian passerine bird, the red-billed leiothrix
Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology·2025
Braden score at ICU admission predicts 30-day mortality in acute pancreatitis
Biomolecules and Biomedicine·2025Open Access
Development of a Culturally Tailored Educational Tool to Increase Somatic Testing Participation Among Black Men With Metastatic Prostate Cancer
JCO oncology advances.·2025Open Access
PARP inhibitors in gastric cancer: unlocking precision oncology
The Oncologist·2025Open Access
The Impact of ARBs and ACE Inhibitors during Chemoradiotherapy on Outcomes for Muscle Invasive Bladder Cancer
International Journal of Radiation Oncology*Biology*Physics·2025
page 1 of 19Next →

Frequent Co-authors

Zhihua Liu(7), Qingyu Luo(5), Xiaowei Wu(5), Slavé Petrovski(4), Hongyan Chen(4), Pengfei Zhao(4), Wan Chang(4), Qinqin Gao(4), Caiping Mao(4), Zhong Ren(3), David B. Goldstein(3), Furong Huang(3), Andrew S. Allen(3), Erin L. Heinzen(3), Yabing Nan(3), Dan Su(3), Yufang Bi(3), Min Xu(3), Yu Xu(3), Guang Ning(3)